Active clinical trials for "Pterygium"

The purpose of this study is to compared between conventional pterygium excision and AMT transplantation with suture and with fibrin glue.

To compare the use of polyglactin sutures versus nylon sutures for conjunctival autograft suturing in pterygium surgery.

The purpose of this study is to determine whether local injection of bevacizumab might halt and or cause regression of pterygium growth. This may enable earlier treatment and prevention of pterygium growth into the patient's line of sight thereby limiting the need for surgery and improving quality of life for patients with pterygia.

To evaluate the recurrence and postoperative complications rates after conjunctival autograft surgery using fibrin adhesive for primary pterygium

DEXTENZA for the treatment of post-surgical pain and inflammation compared to standard of care topical prednisolone acetate 1% in patients who undergo pterygium surgery (excision of pterygium with conjunctival autograft)

To evaluate the use of cultivated conjunctival epithelial equivalents for the treatment of ocular diseases

The purpose of this study is to evaluate the pterygium vascularity and size before and after intralesional ranibizumab injection and to evaluate its recurrence rate following pterygium excision surgery.

The purpose of this study is to determine whether bevacizumab eye drop is effective in the treatment of recurrent pterygium.

Aim of the work: To study the corneal topographic pattern changes in patients who have pterygium excision by two surgical techniques (bare sclera, conjunctival autograft).

This is a randomized controlled trial of postoperative bevacizumab or 5-fluorouracil subconjunctival injections vs placebo for the recurrence of pterygia after excision using conjunctival autograft.